Comments
Loading...
Stime degli utili, EPS e fatturato
Minerva Neurosciences segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 4
Stima EPS
$-0.350
Stima dei ricavi trimestrali
–
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
–
Analizza lo storico degli utili di Minerva Neurosciences utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
NERV | Minerva Neurosciences | $2.97 | -$0.35 | — | — | $0.00 | — | — | — | 11/04/2025 | |
NERV | Minerva Neurosciences | -$1.09 | -$0.92 | -$0.43 | 53.26% | $0.00 | — | $0.00 | — | 08/14/2025 | |
NERV | Minerva Neurosciences | -$1.13 | -$1.07 | -$0.50 | 53.27% | $0.00 | — | $0.00 | — | 05/13/2025 | |
NERV | Minerva Neurosciences | -$1.19 | -$1.05 | -$0.56 | 46.67% | $0.00 | — | $0.00 | — | 02/25/2025 | |
NERV | Minerva Neurosciences | -$1.03 | -$1.01 | $2.97 | 394.06% | $0.00 | — | $0.00 | — | 11/05/2024 | |
NERV | Minerva Neurosciences | -$1.12 | -$0.97 | -$1.09 | -12.37% | $0.00 | — | $0.00 | — | 08/06/2024 | |
NERV | Minerva Neurosciences | -$1.31 | -$1.20 | -$1.13 | 5.83% | $0.00 | — | $0.00 | — | 05/01/2024 | |
NERV | Minerva Neurosciences | -$1.26 | -$0.88 | -$1.19 | -35.23% | $0.00 | — | $0.00 | — | 02/22/2024 | |
NERV | Minerva Neurosciences | -$1.29 | -$0.77 | -$1.03 | -33.77% | $0.00 | — | $0.00 | — | 11/07/2023 | |
NERV | Minerva Neurosciences | -$1.63 | -$0.44 | -$1.12 | -154.55% | $0.00 | — | $0.00 | — | 08/01/2023 | |
NERV | Minerva Neurosciences | -$1.84 | -$1.63 | -$1.31 | 19.63% | $0.00 | — | $0.00 | — | 05/15/2023 | |
NERV | Minerva Neurosciences | -$4.00 | -$0.92 | -$1.26 | -36.96% | $0.00 | — | $0.00 | — | 03/08/2023 | |
NERV | Minerva Neurosciences | -$1.72 | -$1.32 | -$1.29 | 2.27% | $0.00 | — | $0.00 | — | 11/09/2022 | |
NERV | Minerva Neurosciences | -$1.98 | -$1.65 | -$1.63 | 1.21% | $0.00 | — | $0.00 | — | 08/09/2022 | |
NERV | Minerva Neurosciences | -$1.68 | -$1.44 | -$1.84 | -27.78% | $0.00 | — | $0.00 | — | 05/04/2022 | |
NERV | Minerva Neurosciences | -$1.36 | -$1.52 | -$4.00 | -163.16% | $0.00 | — | $0.00 | — | 03/01/2022 | |
NERV | Minerva Neurosciences | -$1.52 | -$1.76 | -$1.76 | 0.00% | $0.00 | $330.00K | $0.00 | -100.00% | 11/08/2021 | |
NERV | Minerva Neurosciences | $5.84 | -$1.36 | -$2.00 | -47.06% | $41.18M | $570.00K | $0.00 | -100.00% | 08/02/2021 | |
NERV | Minerva Neurosciences | -$2.48 | — | -$1.68 | — | $0.00 | $30.00M | $0.00 | -100.00% | 05/12/2021 | |
NERV | Minerva Neurosciences | -$6.16 | -$1.52 | -$1.36 | 10.53% | $0.00 | — | $0.00 | — | 03/08/2021 | |
NERV | Minerva Neurosciences | -$2.88 | -$1.84 | -$1.52 | 17.39% | $0.00 | — | $0.00 | — | 11/02/2020 |
Minerva Neurosciences (NERV) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $-0.43 | $-0.92 | 53.3 % |
| Q1 | 2025-05-13 | $-0.50 | $-1.07 | 53.3 % |
| Q4 | 2025-02-25 | $-0.56 | $-1.05 | 46.7 % |
| Q3 | 2024-11-05 | $2.97 | $-1.01 | 394.1 % |
Minerva Neurosciences (NERV) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2021-11-08 | $0 | $330.00K | -100.0 % |
| Q2 | 2021-08-02 | $0 | $570.00K | -100.0 % |
| Q1 | 2021-05-12 | $0 | $30.00M | -100.0 % |
FAQ
Quando Minerva Neurosciences (NASDAQ:NERV) riporterà gli utili?
Si prevede che Minerva Neurosciences (NERV) fornisca risultati il novembre 4, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Minerva Neurosciences (NASDAQ:NERV)?
L'EPS effettivo era $-0.43, che superato la stima di $-0.92.
Quali sono state le entrate di Minerva Neurosciences (NASDAQ:NERV)?
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.